Generic Portal

— Research Explorer

Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1111/dom.14977
Final published version

Mathias D. G. van den Eynde
Alfons J. H. M. Houben
Jean L. J. M. Scheijen
Armand M. A. Linkens
Petra M. Niessen
Nynke Simons
Nordin M. J. Hanssen
Yvo H. A. M. Kusters
Simone J. M. P. Eussen
Toshio Miyata
Coen D. A. Stehouwer
Casper G. Schalkwijk

Original language	English
Pages (from-to)	1280-1291
Number of pages	12
Journal	Diabetes, Obesity and Metabolism
Volume	25
Issue number	5
Early online date	2023
DOIs	https://doi.org/10.1111/dom.14977
Publication status	Published - May 2023

Research areas

(micro)vascular function, abdominal obesity, advanced glycation endproducts, dicarbonyl stress, insulin sensitivity, pyridoxamine

ID: 33267095